Literature DB >> 19915511

Clinical and molecular epidemiology of rotavirus in children with community-acquired and hospital-acquired diarrhea in Shanghai, China.

Mei Zeng1, Yuxia Zhang, Qirong Zhu, Xiaohong Wang, Hui Yu.   

Abstract

A hospital-based investigation was conducted to understand the epidemiologic profile of rotavirus diarrhea due to community-acquired and hospital-acquired infection among children >28 days of age, between November 2006 and January 2008 in Shanghai. Rotavirus infection was related to 37.2% of clinic visit and 48.1% of ward admission attributable to community-acquired noninvasive bacterial diarrhea among Shanghainese children. Rotavirus was responsible for 54.8% of nosocomial diarrhea. G3P[8] (56.8%) was the most prevalent, followed by G1P[8] (15.8%), G2P[4] (3.0%), and G9P[8] (2.3%).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19915511     DOI: 10.1097/INF.0b013e3181ba99d4

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

2.  Molecular epidemiology of rotavirus A and adenovirus among children with acute diarrhea in Hangzhou, China.

Authors:  Wei Li; Wenqing Xiang; Cixiu Li; Jialu Xu; Dongming Zhou; Shiqiang Shang
Journal:  Gut Pathog       Date:  2020-04-13       Impact factor: 4.181

3.  Study of the changes in immune indexes, pathogenic characteristics and related risk factors in children with viral diarrhea.

Authors:  Di-Ying Wang; Feng Zhan; Hui-Ling Liu
Journal:  Transl Pediatr       Date:  2021-10

4.  Frequency of rotavirus and adenovirus gastroenteritis among children in shiraz, iran.

Authors:  Mohammad Motamedifar; Elham Amini; Pedram Talezadeh Shirazi
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.